Clincosm LogoSign in Get a demo

carcinoma, hepatocellular

Showing 1 - 25 of 259
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CT Imaging for Guiding PA-TACE for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • postoperative adjuvant transarterial chemoembolization
  • Guangzhou, Guangdong, China
    ZhuJiang Hospital of Southern Medical University
Nov 30, 2023

Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis Trial in United States (GALAD, Liver Ultrasound with or without AFP)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • +3 more
  • GALAD
  • Liver Ultrasound with or without AFP
  • Los Angeles, California
  • +9 more
Oct 18, 2023

Carcinoma, Hepatocellular, Metabolic Syndrome Trial in Lecce (Liver resection and simultaneous sleeve gastrectomy for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • Metabolic Syndrome
  • Liver resection and simultaneous sleeve gastrectomy for HCC induced by metabolic syndrome
  • Liver resection for HCC induced by metabolic syndrome
  • Lecce, Italy
    Ospedale Vito Fazzi
Sep 23, 2023

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 15, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 14, 2023

Population in Improving Eearly Diagnosis Efficancy in Chinese

Recruiting
  • Carcinoma, Hepatocellular
  • +4 more
  • Liver cancer surveillance every 3 months
  • +2 more
  • Shanghai, Shanghai, China
    Department of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023

Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)

Recruiting
  • Carcinoma
  • +2 more
  • 99mTc-Macro Albumin Aggregate
  • Spokane, Washington
    Inland Imaging
May 4, 2023

Carcinoma, Hepatocellular Trial in Worldwide (Relatlimab, Nivolumab, Bevacizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +62 more
Feb 1, 2023

Carcinoma, Hepatocellular Trial in India (Lenvatinib)

Recruiting
  • Carcinoma, Hepatocellular
  • Bangalore, Karnataka, India
  • +10 more
Feb 1, 2023

Carcinoma, Hepatocellular Trial in Worldwide (drug, biological, procedure)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Tucson, Arizona
  • +206 more
Jan 31, 2023

Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)

Completed
  • Carcinoma, Hepatocellular
  • +3 more
  • Duarte, California
  • +9 more
Jan 27, 2023

Carcinoma, Hepatocellular Trial in China (Amivantamab)

Recruiting
  • Carcinoma, Hepatocellular
  • Beijing, China
  • +15 more
Jan 27, 2023

Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 23, 2023

Lenvima in Korean Unresectable Hepatocellular Carcinoma

Completed
  • Liver Neoplasms
  • Carcinoma, Hepatocellular
  • Non-interventional
  • Cheonan, Chungcheongnam-do, Korea, Republic of
  • +41 more
Jan 6, 2023

Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)

Completed
  • Carcinoma, Hepatocellular
  • Hepatoma
  • Seongnam, Korea, Republic of
  • +2 more
Dec 4, 2022

Carcinoma, Hepatocellular Trial in Spain (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Elche, Alicante, Spain
  • +26 more
Dec 5, 2022

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Carcinoma, Hepatocellular Trial in São Paulo (PET MRI with PSMA)

Recruiting
  • Carcinoma, Hepatocellular
  • PET MRI with PSMA
  • São Paulo, Brazil
    University of Sao Paulo
Oct 11, 2022

Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)

Recruiting
  • Carcinoma, Hepatocellular
  • Liver Cell Carcinoma
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Vascular Invasion Signatures in cfDNA Support Re-staging of

Completed
  • Carcinoma, Hepatocellular
  • +2 more
  • Liver resection
  • Shanghai, Shanghai, China
    Eastern Hepatobiliary Surgery Hospital, Naval Medical University
Sep 15, 2022

Hepatoblastoma, Carcinoma, Hepatocellular Trial in Aberdeen, Cambridge (Cisplatin, Doxorubicin, Carboplatin)

Recruiting
  • Hepatoblastoma
  • Carcinoma, Hepatocellular
  • Vienna, Austria
  • +30 more
Sep 5, 2022

Carcinoma, Hepatocellular Trial in China, Korea, Republic of, Taiwan (Tepotinib 300 mg, Tepotinib 500 mg, Tepotinib 1000 mg)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Tepotinib 300 mg
  • +4 more
  • Beijing, Beijing, China
  • +42 more
Aug 22, 2022

Carcinoma, Hepatocellular Trial in Darmstadt (Tepotinib)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Darmstadt, Germany
    Please contact the Merck KGaA Communication Center located in
Aug 22, 2022

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +138 more
Aug 22, 2022